Therapeutic use of citrulline in cardiovascular disease.
about
Deficient BH4 production via de novo and salvage pathways regulates NO responses to cytokines in adult cardiac myocytesGenetic Architecture of Atherosclerosis in Mice: A Systems Genetics Analysis of Common Inbred StrainsAsymmetric Dimethylarginine Is a Well Established Mediating Risk Factor for Cardiovascular Morbidity and Mortality-Should Patients with Elevated Levels Be Supplemented with Citrulline?Arginase induction and activation during ischemia and reperfusion and functional consequences for the heartCharacteristics of L-citrulline transport through blood-brain barrier in the brain capillary endothelial cell line (TR-BBB cells).Restoration of asymmetric dimethylarginine-nitric oxide balance to prevent the development of hypertension.Local arginase inhibition during early reperfusion mediates cardioprotection via increased nitric oxide production.Asymmetric dimethylarginine is associated with developmental programming of adult kidney disease and hypertension in offspring of streptozotocin-treated mothers.New approaches to the design and discovery of therapies to prevent erectile dysfunction.Long-term effects of maternal citrulline supplementation on renal transcriptome prevention of nitric oxide depletion-related programmed hypertension: the impact of gene-nutrient interactions.Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway.L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.Angiotensin II limits NO production by upregulating arginase through a p38 MAPK-ATF-2 pathwayEffects of Oral L-Citrulline Supplementation on Lipoprotein Oxidation and Endothelial Dysfunction in Humans with Vasospastic AnginaL-Citrulline increases hepatic sensitivity to insulin by reducing the phosphorylation of serine 1101 in insulin receptor substrate-1.Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway.Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic micePharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolismOral L-citrulline supplementation enhances cycling time trial performance in healthy trained men: Double-blind randomized placebo-controlled 2-way crossover studyThe immediate effect of nitric oxide on the rabbit bladder after ovariectomyl-Citrulline Protects from Kidney Damage in Type 1 Diabetic Mice.Streptococcus pyogenes arginine and citrulline catabolism promotes infection and modulates innate immunity.Supplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.The effect of nitric-oxide-related supplements on human performance.Citrulline and nitrogen homeostasis: an overview.The Importance of Quality Specifications in Safety Assessments of Amino Acids: The Cases of l-Tryptophan and l-Citrulline.Diabetes-induced coronary vascular dysfunction involves increased arginase activityAnalysis of L-citrulline and L-arginine in Ficus deltoidea leaf extracts by reverse phase high performance liquid chromatography.Boosting endogenous production of vasoprotective hydrogen sulfide via supplementation with taurine and N-acetylcysteine: a novel way to promote cardiovascular health.Targeting aspirin resistance with nutraceuticals: a possible strategy for reducing cardiovascular morbidity and mortality.Vitamin C prevents DNA damage induced by renovascular hypertension in multiple organs of Wistar rats.Oral L-citrulline supplementation attenuates blood pressure response to cold pressor test in young men.Ethnicity-specific differences in L-arginine status in South African men.The effects of short term L-citrulline supplementation on wave reflection responses to cold exposure with concurrent isometric exercise.L-Citrulline Supplementation Enhances Fetal Growth and Protein Synthesis in Rats with Intrauterine Growth Restriction.Dose-ranging effects of citrulline administration on plasma amino acids and hormonal patterns in healthy subjects: the Citrudose pharmacokinetic study.Dietary interventions for fetal growth restriction - therapeutic potential of dietary nitrate supplementation in pregnancy.Administration of L-arginine plus L-citrulline or L-citrulline alone successfully retarded endothelial senescence.Kidney Mass Reduction Leads to l-Arginine Metabolism-Dependent Blood Pressure Increase in Mice.
P2860
Q24653313-8496A3C0-44F2-4EC6-9318-F6C9BDAF278AQ27309881-3EB9B6C7-3777-4822-975C-DF553054190EQ28075206-8F508195-EFA3-43B6-8F75-DD44DC122E6DQ28081566-E0EBB7CD-F34D-4ED8-B776-555F8B90D6C4Q33655373-4CEC1134-6931-4329-B0FD-86DC94C271B5Q34072296-B3B66FBA-8B9A-4D95-B999-DB1A1BFD65CFQ34364451-AEE11C8C-E834-46EF-A953-993D9557BF13Q34586038-BE91617D-4165-4825-8041-F928F243367DQ34664336-8B7C96E6-9CEB-4166-8A37-C0F1EAB47B88Q34835432-486CBE83-E156-4E2A-8ED8-8BC8ACBB29F7Q34979275-994BA978-436D-4F1B-A3ED-914C4C72C0A3Q35093512-6276FF5E-6630-41E9-B9A2-1686CCB6B3AFQ35545549-9EB7000B-C819-4FD2-8684-54EA2E882EA1Q35618773-46677835-689D-49CB-8B16-77C6EBE32CD7Q35666520-1A1B0FAF-0A7D-43DB-AECF-865EA567F723Q35708220-85CA298C-9025-41BE-8E25-26E4B20AB859Q35849496-F383C333-5E6E-476D-B41A-812C61372568Q36536026-D28C6F57-D291-4826-BB50-529EDF201F9EQ36596357-419BFCEB-43DA-4636-827A-99FACD130191Q37138090-5457C73C-0BCB-4B2C-B809-9A894CF341B2Q37412089-E9D6E4E4-12B7-4840-9EEA-67F4422959E8Q37548051-B858C604-5EC5-4AE0-9AC4-9320B29F1FEEQ37728038-E58C28C1-8DB0-47C1-A849-F53708FFAE07Q37798082-CC920335-8ECD-469F-8F40-6AE832D10EB3Q37977148-2570C64B-B564-46C1-82A0-52FB6E7870CCQ38353698-BDB9598F-2DBC-4AFA-BFFA-1E21F7F600A6Q39033996-884136D3-7FBB-4A35-AC2A-A82821A35392Q41817278-B90CC5A3-0A5F-48C8-9544-4335B4435216Q41821950-163345C3-720C-45D2-8D67-87C5449A2508Q42338456-D04C80C3-F94B-4D96-B3DD-E2F88B4960ECQ42355197-4C5D585E-33A4-4000-B760-EE4CE867657BQ43201214-27A92098-0E5B-477C-9447-F25C29668430Q43256273-B1421B90-55E0-48E9-A6D0-B7FCAA5932E5Q44541761-7916556B-9562-47BC-B406-B2684845A1A0Q45444073-E41EB033-E91D-497F-9A2F-2EB55B67B61EQ46309473-A706840A-0869-4DF4-95D6-E6A248E62972Q46937390-9278AF68-A36A-4CC7-99F2-CAB51C14530DQ48351024-DBA2CAEF-8E75-4ABC-860E-762A7A61E141Q50133226-65A075CF-1375-4217-ACF8-41D9500D2ED2Q51747901-FD7205DE-D0DE-49F1-87E8-4A778816DFA6
P2860
Therapeutic use of citrulline in cardiovascular disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Therapeutic use of citrulline in cardiovascular disease.
@ast
Therapeutic use of citrulline in cardiovascular disease.
@en
type
label
Therapeutic use of citrulline in cardiovascular disease.
@ast
Therapeutic use of citrulline in cardiovascular disease.
@en
prefLabel
Therapeutic use of citrulline in cardiovascular disease.
@ast
Therapeutic use of citrulline in cardiovascular disease.
@en
P2093
P2860
P1476
Therapeutic use of citrulline in cardiovascular disease.
@en
P2093
Daniel H Platt
Maritza J Romero
R William Caldwell
Ruth B Caldwell
P2860
P304
P356
10.1111/J.1527-3466.2006.00275.X
P577
2006-09-01T00:00:00Z